newsletter, page-2

G'day,

A couple of significant points from the Newsletter.

1. New European HQ to be established in Germany. This augers well for QFT becoming the only TB test used in Germany. (Germany are in the market for a new test as they have all but abandoned the skin test)

2. US Medicaid now reimburses for QFT testing

3. Results of trials submitted to the FDA allow CST to quote 99.8% specificity for QFT-TB Gold

lots more ... I guess you can read it for yourself.